Sarzi Puttini 1988.
Study characteristics | ||
Methods | Design: parallel Duration: 4 weeks Assessment: baseline and post‐intervention Country: Italy |
|
Participants | Pain condition: RA Population: adults with RA and with or without depression Minimum pain intensity: ≥ 50 on 0‐100 scale Inclusion criteria
Exclusion criteria: NR Total participants randomised: 60 Age in years (mean, SD): NR Gender: 52/60 were female Pain duration in years (mean, SD): NR |
|
Interventions | Placebo
Dothiepin 75 mg
|
|
Outcomes | Study provided no useable data | |
Missing data methods | Completer analysis | |
Funding source | NR | |
Conflicts of interest | NR | |
Notes | ||
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Randomisation methods not specified |
Allocation concealment (selection bias) | Unclear risk | Allocation methods not specified |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Says matched dosing schedules but not other information given |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Self‐reported outcomes from participants but unsure of blinding |
Incomplete outcome data (attrition bias) All outcomes | High risk | Completer analysis only Attrition Total: 10/60 (16.7%) Attrition per arm NR |
Selective reporting (reporting bias) | Unclear risk | No protocol or trial registration found |
Other bias | Low risk | No other sources of bias were identified |